Chemotherapy Drug Shortages in the United States: Genesis and Potential Solutions

2012 ◽  
Vol 30 (7) ◽  
pp. 692-694 ◽  
Author(s):  
Michael P. Link ◽  
Karen Hagerty ◽  
Hagop M. Kantarjian
2014 ◽  
Vol 10 (5) ◽  
pp. 329-331 ◽  
Author(s):  
Hagop Kantarjian

The practices of group purchasing organizations have been recently highlighted by several sources as a potential major root cause of generic chemotherapy drug shortages.


PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0134597 ◽  
Author(s):  
James C. Scott ◽  
Neha Shah ◽  
Travis Porco ◽  
Jennifer Flood

2016 ◽  
Vol 51 (5) ◽  
pp. 370-375 ◽  
Author(s):  
Mona Alsheikh ◽  
Enrique Seoane-Vazquez ◽  
Brian Rittenhouse ◽  
Erin R. Fox ◽  
John Fanikos

JAMA ◽  
2020 ◽  
Vol 323 (9) ◽  
pp. 819
Author(s):  
Inmaculada Hernandez ◽  
Tina Batra Hershey ◽  
Julie M. Donohue

2020 ◽  
Vol 35 (3) ◽  
pp. 110-112
Author(s):  
Rosemary Gibson

The U.S. health care system is becoming increasingly dependent on China for medicines because it is the dominant world supplier of the ingredients needed to make thousands of medicines distributed to hospitals, pharmacies, and military hospitals. The United States is so dependent that if China stopped supplying ingredients, pharmacy shelves would be empty within months. The Food and Drug Administration is in the unenviable position of making tradeoffs between assuring high standards that Americans have come to expect and preventing drug shortages.


2012 ◽  
Vol 54 (5) ◽  
pp. 684-691 ◽  
Author(s):  
M. M. Griffith ◽  
A. E. Gross ◽  
S. H. Sutton ◽  
M. K. Bolon ◽  
J. S. Esterly ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document